High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome

Beneficial Microbes

Volumn 7, Issue 2, 2016, Pages 247-264

  Monteagudo Mera, A ^a   Arthur, J C ^a   Jobin, C ^a,b   Keku, T ^a   Bruno Barcena, J M ^c   Azcarate Peril, M A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c Department of Plant and Microbial Biology ^*  (United States)

Author keywords

Bifidobacterium; Mouse gut microbiome; Prebiotics

Indexed keywords

ACETIC ACID; BACTERIAL DNA; BIOLOGICAL MARKER; BUTYRIC ACID; DNA 16S; GALACTOSE OLIGOSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTIC ACID; PREBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; GALACTOSE; OLIGOSACCHARIDE;

AMPLICON; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL METABOLISM; BACTEROIDALES; BACTEROIDES; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM GALLICUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; CLOSTRIDIALES; CLOSTRIDIUM; COLON ABSORPTION; CONTROLLED STUDY; FEMALE; HELICOBACTER; INFLAMMATION; INTESTINE FLORA; LACTOBACILLUS; MALE; MICROBIAL DIVERSITY; MOUSE; NONHUMAN; PHYLOGENY; PYROSEQUENCING; 129 MOUSE; ANIMAL; BACTERIUM; CLASSIFICATION; FERMENTATION; GASTROINTESTINAL TRACT; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; BACTERIA; BIFIDOBACTERIUM; FEMALE; FERMENTATION; GALACTOSE; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; INTERLEUKIN-12; INTERLEUKIN-6; MALE; MICE; MICE, 129 STRAIN; OLIGOSACCHARIDES; PREBIOTICS;

EID: 84961837293     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2015.0114     Document Type: Article

References (90)

1. Anthony, J.C., Merriman, T.N. and Heimbach, J.T., 2006. 90-day oral (gavage) study in rats with galactooligosaccharides syrup. Food and Chemical Toxicology 44: 819-826.
2. Arslanoglu, S., Moro, G.E., Schmitt, J., Tandoi, L., Rizzardi, S. and Boehm, G., 2008. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. Journal of Nutrition 138: 1091-1095.
3. Ben, X.-M., Li, J., Feng, Z.-T., Shi, S.-Y., Lu, Y.-D., Chen, R. and Zhou, X.-Y., 2008. Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal bifidobacteria and lactobacilli. World Journal of Gastroenterology 14: 6564-6568.
4. Bernbom, N., Norrung, B., Saadbye, P., Molbak, L., Vogensen, F.K. and Licht, T.R., 2006. Comparison of methods and animal models commonly used for investigation of fecal microbiota: effects of time, host and gender. Journal of Microbiological Methods 66: 87-95.
5. Boente, R.F., Ferreira, L.Q., Falcao, L.S., Miranda, K.R., Guimaraes, P.L., Santos-Filho, J., Vieira, J.M., Barroso, D.E., Emond, J.P., Ferreira, E.O., Paula, G.R. and Domingues, R.M., 2010. Detection of resistance genes and susceptibility patterns in Bacteroides and Parabacteroides strains. Anaerobe 16: 190-194.
6. Bolnick, D.I., Snowberg, L.K., Hirsch, P.E., Lauber, C.L., Org, E., Parks, B., Lusis, A.J., Knight, R., Caporaso, J.G. and Svanback, R., 2014. Individual diet has sex-dependent effects on vertebrate gut microbiota. Nature Communications 5: 4500.
7. Bruno-Barcena, J.M. and Azcarate-Peril, M.A., 2015. Galactooligosaccharides and colorectal cancer: feeding our intestinal probiome. Journal of Functional Foods 12: 92-108.
8. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Pena, A.G., Goodrich, J.K., Gordon, J.I., Huttley, G.A., Kelley, S.T., Knights, D., Koenig, J.E., Ley, R.E., Lozupone, C.A., McDonald, D., Muegge, B.D., Pirrung, M., Reeder, J., Sevinsky, J.R., Turnbaugh, P.J., Walters, W.A., Widmann, J., Yatsunenko, T., Zaneveld, J. and Knight, R., 2010. QIIME allows analysis of high-throughput community sequencing data. Nature Methods 7: 335-336.
9. Chang, J.Y., Antonopoulos, D.A., Kalra, A., Tonelli, A., Khalife, W.T., Schmidt, T.M. and Young, V.B., 2008. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. Journal of Infectious Diseases 197: 435-438.
10. Chassy, B.M. and Thompson, J., 1983. Regulation and characterization of the galactose-phosphoenolpyruvate-dependent phosphotransferase system in Lactobacillus casei. Journal of Bacteriology 154: 1204-1214.
11. Dagher, S.F., Azcarate-Peril, M.A. and Bruno-Barcena, J.M., 2013. Heterologous expression of a bioactive beta-hexosyltransferase, an enzyme producer of prebiotics, from Sporobolomyces singularis. Applied and Environmental Microbiology 79: 1241-1249.
12. Davis, L.M., Martinez, I., Walter, J., Goin, C. and Hutkins, R.W., 2011. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PloS ONE 6: e25200.
13. Davis, L.M., Martinez, I., Walter, J. and Hutkins, R., 2010. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. International Journal of Food Microbiology 144: 285-292.
14. De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J.B., Massart, S., Collini, S., Pieraccini, G. and Lionetti, P., 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proceedings of the National Academy of Sciences of the USA 107: 14691-14696.
15. Devine, A.A., Gonzalez, A., Speck, K.E., Knight, R., Helmrath, M., Lund, P.K. and Azcarate-Peril, M.A., 2013. Impact of ileocecal resection and concomitant antibiotics on the microbiome of the murine jejunum and colon. PloS ONE 8: e73140.
16. Dibaise, J., Frank, D.N., Mathur, R. and FRCPC, 2012. Impact of the gut microbiotaon the development of obesity: Current concepts. American Journal of Gastreoenterology Suppl. 1: 22-27.
17. Edgar, R.C., 2010. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26: 2460-2461.
18. Edwards, U., Rogall, T., Blocker, H., Emde, M. and Bottger, E.C., 1989. Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA. Nucleic Acids Research 17: 7843-7853.
19. Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G.G., Neyrinck, A.M., Possemiers, S., Van Holle, A., Francois, P., De Vos, W.M., Delzenne, N.M., Schrenzel, J. and Cani, P.D., 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60: 2775-2786.
20. Fierer, N., Hamady, M., Lauber, C.L. and Knight, R., 2008. The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proceedings of the National Academy of Sciences of the USA 105: 17994-17999.
21. Gibson, G.R., Probert, H.M., Loo, J.V., Rastall, R.A. and Roberfroid, M.B., 2004. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutrition Research Reviews 17: 259-275.
22. Gopal, P.K., Ramsay, R., Sullivan, P.A. and Smart, J.B., 2001. Growth promoting effects of galactooligosaccharides on B. lactis HN010 (DR10) and L. rhamnosus HN001 (DR20). American Journal of Clinical Nutrition 73: 496S-496S.
23. Gopalakrishnan, A., Clinthorne, J.F., Rondini, E.A., McCaskey, S.J., Gurzell, E.A., Langohr, I.M., Gardner, E.M. and Fenton, J.I., 2012. Supplementation with galacto-oligosaccharides increases the percentage of NK cells and reduces colitis severity in Smad3-deficient mice. Journal of Nutrition 142: 1336-1342.
24. Gourbeyre, P., Desbuards, N., Gremy, G., Tranquet, O., Champ, M., Denery-Papini, S. and Bodinier, M., 2013. Perinatal and postweaning exposure to galactooligosaccharides/inulin prebiotics induced biomarkers linked to tolerance mechanism in a mouse model of strong allergic sensitization. Journal of Agricultural and Food Chemistry 61: 6311-6320.
25. Gueimonde, M., Tolkko, S., Korpimaki, T. and Salminen, S., 2004. New real-time quantitative PCR procedure for quantification of bifidobacteria in human fecal samples. Applied and Environmental Microbiology 70: 4165-4169.
26. Haas, B.J., Gevers, D., Earl, A.M., Feldgarden, M., Ward, D.V., Giannoukos, G., Ciulla, D., Tabbaa, D., Highlander, S.K., Sodergren, E., Methe, B., DeSantis, T.Z., Petrosino, J.F., Knight, R. and Birren, B.W., 2011. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Research 21: 494-504.
27. Hansen, R., G.L. Hold, S.H. Berry, J.M. Thomson, N.E. El-Sakka, W.M. Bisset, G. Mahdi, G.I. Murray, P.J. Helms and E.M. El-Omar, 2009. The prevalence of non-pylori Helicobacter organisms in paediatric inflammatory bowel disease. Gut 58: A289.
28. Hermann-Bank, M.L., Skovgaard, K., Stockmarr, A., Larsen, N. and Molbak, L., 2013. The Gut Microbiotassay: a high-throughput qPCR approach combinable with next generation sequencing to study gut microbial diversity. BMC Genomics 14: 788.
29. Hopkins, M.J. and Macfarlane, G.T., 2003. Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Applied and Environmental Microbiology 69: 1920-1927.
30. Horie, H., Kanazawa, K., Okada, M., Narushima, S., Itoh, K. and Terada, A., 1999. Effects of intestinal bacteria on the development of colonic neoplasm: an experimental study. European Journal of Cancer Prevention 8: 237-245.
31. Ito, M., Deguchi, Y., Miyamori, A., Matsumoto, K., Kikuchi, H., Matsumoto, K., Kobayashi, Y., Yajima, T. and Kan, T., 1990. Effects of administration of galactooligosaccharides on the human faecal microflora, stool weight and abdominal sensation. Microbial Ecology in Health and Disease 3: 285-292.
32. Junick, J. and Blaut, M., Quantification of human fecal Bifidobacterium species by use of quantitative real-time PCR analysis targeting the groEL gene. Applied and Environmental Microbiology 78: 2613-2622.
33. Kanatani, K., Tahara, T., Yoshida, K., Miura, H., Sakamoto, M. and Oshimura, M., 1992. Plasmid-linked galactose utilization by Lactobacillus acidophilus TK8912. BBioscience, Biotechnology and Biochemistry 56: 826-827.
34. Komiyama, Y., Andoh, A., Fujiwara, D., Ohmae, H., Araki, Y., Fujiyama, Y., Mitsuyama, K. and Kanauchi, O., 2011. New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system. Scandinavian Journal of Gastroenterology 46: 40-52.
35. Kunz, C., Rudloff, S., Baier, W., Klein, N. and Strobel, S., 2000. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annual Review of Nutrition 20: 699-722.
36. Kwon, H.-S., Yang, E.-H., Lee, S.-H., Yeon, S.-W., Kang, B.-H. and Kim, T.-Y., 2006. Rapid identification of potentially probiotic Bifidobacterium species by multiplex PCR using species-specific primers based on the region extending from 16S rRNA through 23 S rRNA. FEMS Microbiology Letters 250: 55-62.
37. Laharie, D., Asencio, C., Asselineau, J., Bulois, P., Bourreille, A., Moreau, J., Bonjean, P., Lamarque, D., Pariente, A., Soule, J.C., Charachon, A., Coffin, B., Perez, P., Megraud, F. and Zerbib, F., 2009. Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional study. Alimentary Pharmacology and Therapeutics 30: 283-293.
38. Lozupone, C., Hamady, M. and Knight, R., 2006. UniFrac-an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinformatics 7: 371.
39. Macfarlane, G.T., Steed, H. and Macfarlane, S., 2008. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. Journal of Applied Microbiology 104: 305-344.
40. Maeda, H., Fujimoto, C., Haruki, Y., Maeda, T., Kokeguchi, S., Petelin, M., Arai, H., Tanimoto, I., Nishimura, F. and Takashiba, S., 2003. Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria. FEMS Immunology and Medical Microbiology 39: 81-86.
41. Manichanh, C., Rigottier-Gois, L., Bonnaud, E., Gloux, K., Pelletier, E., Frangeul, L., Nalin, R., Jarrin, C., Chardon, P., Marteau, P., Roca, J. and Dore, J., 2006. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55: 205-211.
42. Markle, J.G., Frank, D.N., Mortin-Toth, S., Robertson, C.E., Feazel, L.M., Rolle-Kampczyk, U., Von Bergen, M., McCoy, K.D., Macpherson, A.J. and Danska, J.S., 2013. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339: 1084-1088.
43. Martinez, I., Kim, J., Duffy, P.R., Schlegel, V.L. and Walter, J., 2010. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PloS One 5: e15046.
44. Martinez, I., Wallace, G., Zhang, C., Legge, R., Benson, A.K., Carr, T.P., Moriyama, E.N. and Walter, J., 2009. Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Applied and Environmental Microbiology 75: 4175-4184.
45. Martinez, R.C., Aynaou, A.E., Albrecht, S., Schols, H.A., De Martinis, E.C., Zoetendal, E.G., Venema, K., Saad, S.M. and Smidt, H., 2011. In vitro evaluation of gastrointestinal survival of Lactobacillus amylovorus DSM 16698 alone and combined with galactooligosaccharides, milk and/or Bifidobacterium animalis subsp. lactis Bb-12. International Journal of Food Microbiology 149: 152-158.
46. Matsuki, T., Watanabe, K., Fujimoto, J., Kado, Y., Takada, T., Matsumoto, K. and Tanaka, R., 2004. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Applied and Environmental Microbiology 70: 167-173.
47. Matsuki, T., Watanabe, K., Tanaka, R., Fukuda, M. and Oyaizu, H., 1999. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Applied and Environmental Microbiology 65: 4506-4512.
48. McCafferty, J., Muhlbauer, M., Gharaibeh, R.Z., Arthur, J.C., Perez-Chanona, E., Sha, W., Jobin, C. and Fodor, A.A., 2013. Stochastic changes over time and not founder effects drive cage effects in microbial community assembly in a mouse model. ISME Journal 7: 2116-2125.
49. Milani, C., Duranti, S., Lugli, G.A., Bottacini, F., Strati, F., Arioli, S., Foroni, E., Turroni, F., van Sinderen, D. and Ventura, M., 2013. Comparative genomics of Bifidobacterium animalis subsp. lactis reveals a strict monophyletic bifidobacterial taxon. Applied and Environmental Microbiology 79: 4304-4315.
50. Morishita, Y., Oowada, T., Ozaki, A. and Mizutani, T., 2002. Galactooligosaccharide in combination with Bifidobacterium and Bacteroides affects the population of Clostridium perfringens in the intestine of gnotobiotic mice. Nutrition Research 22: 1333-1341.
51. Nakayama, T. and Oishi, K., 2013. Influence of coffee (Coffea arabica) and galacto-oligosaccharide consumption on intestinal microbiota and the host responses. FEMS Microbiology Letters 343: 161-168.
52. Ohland, C.L., Kish, L., Bell, H., Thiesen, A., Hotte, N., Pankiv, E. and Madsen, K.L., 2013. Effects of Lactobacillus helveticus on murine behavior are dependent on diet and genotype and correlate with alterations in the gut microbiome. Psychoneuroendocrinology 38: 1738-1747.
53. Onoue, M., Kado, S., Sakaitani, Y., Uchida, K. and Morotomi, M., 1997. Specific species of intestinal bacteria influence the induction of aberrant crypt foci by 1, 2-dimethylhydrazine in rats. Cancer Letters 113: 179-186.
54. Pan, X.D., Chen, F.Q., Wu, T.X., Tang, H.G. and Zhao, Z.Y., 2009. Prebiotic oligosaccharides change the concentrations of short-chain fatty acids and the microbial population of mouse bowel. Journal of Zhejiang University Science B 10: 258-263.
55. Pedersen, A., Sandstrom, B. and Van Amelsvoort, J.M., 1997. The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. British Journal of Nutrition 78: 215-222.
56. Plummer, M., Franceschi, S., Vignat, J., Forman, D. and De Martel, C., 2014. Global burden of gastric cancer attributable to pylori. International Journal of Cancer 136: 487-490.
57. Polk, D.B. and Peek Jr., R.M., 2010. Helicobacter pylori: gastric cancer and beyond. Nature Reviews Cancer 10: 403-414.
58. Prasad, J., Sazawal, S., Dhingra, U. and Gopal, P.K., 2013. Detection of viable Bifidobacterium lactis HN019 (DR10™) in stools of children during a synbiotic dietary intervention trial. International Dairy Journal 30: 64-67.
59. Quintero, M., Maldonado, M., Perez-Munoz, M., Jimenez, R., Fangman, T., Rupnow, J., Wittke, A., Russell, M. and Hutkins, R., 2011. Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by prebiotic oligosaccharides. Current Microbiology 62: 1448-1454.
60. Rabiu, B.A., Jay, A.J., Gibson, G.R. and Rastall, R.A., 2001. Synthesis and fermentation properties of novel galacto-oligosaccharides by beta-galactosidases from Bifidobacterium species. Applied and Environmental Microbiology 67: 2526-2530.
61. Rastall, R.A. and Maitin, V., 2002. Prebiotics and synbiotics: towards the next generation. Current Opinion in Biotechnology 13: 490-496.
62. Rinne, M.M., Gueimonde, M., Kalliomaki, M., Hoppu, U., Salminen, S.J. and Isolauri, E., 2005. Similar bifidogenic effects of prebioticsupplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunology and Medical Microbiology 43: 59-65.
63. Rowland, I.R., 2009. The role of the gastrointestinal microbiota in colorectal cancer. Current Pharmaceutical Design 15: 1524-1527.
64. Russell, S.L., Gold, M.J., Hartmann, M., Willing, B.P., Thorson, L., Wlodarska, M., Gill, N., Blanchet, M.R., Mohn, W.W., McNagny, K.M. and Finlay, B.B., 2012. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Reports 13: 440-447.
65. Sangwan, V., Tomar, S.K., Singh, R.R., Singh, A.K. and Ali, B., 2011. Galactooligosaccharides: novel components of designer foods. Journal of Food Science 76: R103-R111.
66. Santos, A., San Mauro, M. and Diaz, D.M., 2006. Prebiotics and their long-term influence on the microbial populations of the mouse bowel. Food Microbiology 23: 498-503.
67. Schmittgen, T.D. and Livak, K.J., 2008. Analyzing real-time PCR data by the comparative C(T) method. Nature Protocols 3: 1101-1108.
68. Schwab, C. and Ganzle, M., 2011. Lactic acid bacteria fermentation of human milk oligosaccharide components, human milk oligosaccharides and galactooligosaccharides. FEMS Microbiology Letters 315: 141-148.
69. Scott, K.P., Martin, J.C., Duncan, S.H. and Flint, H.J., 2014. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiology Ecology 87: 30-40.
70. Searle, L.E., Best, A., Nunez, A., Salguero, F.J., Johnson, L., Weyer, U., Dugdale, A.H., Cooley, W.A., Carter, B., Jones, G., Tzortzis, G., Woodward, M.J. and La Ragione, R.M., 2009. A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice. Journal of Medical Microbiology 58: 37-48.
71. Sekirov, I., Russell, S.L., Antunes, L.C. and Finlay, B.B., 2010. Gut microbiota in health and disease. Physiological Reviews 90: 859-904.
72. Senevirathne, R.N., Janes, M., Keenan, M.J., Martin, R.J., Raggio, A.M., McCutcheon, K.L., Tulley, R.T. and Zhou, J., 2009. Dietary resistant starch increases Bifidobacterium spp./Lactobacillus spp and Clostridia spp. in the gut of mice fed low and moderate fat diets. FASEB Journal 28 Suppl.: 719.6.
73. Shoaf, K., Mulvey, G.L., Armstrong, G.D. and Hutkins, R.W., 2006. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infection and Immunity 74: 6920-6928.
74. Silk, D.B., Davis, A., Vulevic, J., Tzortzis, G. and Gibson, G.R., 2009. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 29: 508-518.
75. Silvi, S., Rumney, C.J., Cresci, A. and Rowland, I.R., 1999. Resistant starch modifies gut microflora and microbial metabolism in human flora-associated rats inoculated with faeces from Italian and UK donors. Journal of Applied Microbiology 86: 521-530.
76. Stone-Dorshow, T. and Levitt, M.D., 1987. Gaseous response to ingestion of a poorly absorbed fructo-oligosaccharide sweetener. American Journal of Clinical Nutrition 46: 61-65.
77. Tanabe, S. and Hochi, S., 2010. Oral administration of a galactooligosaccharide preparation inhibits development of atopic dermatitis-like skin lesions in NC/Nga mice. International Journal of Molecular Medicine 25: 331-336.
78. Thompson, A.L., Monteagudo-Mera, A., Cadenas, M.B., Lampl, M.L. and Azcarate-Peril, M.A., 2015. Milk-and solid-feeding practices and daycare attendance are associated with differences in bacterial diversity, predominant communities, and metabolic and immune function of the infant gut microbiome. Frontiers in Cellular and Infection Microbiology 5: 3.
79. Tuohy, K.M., Rouzaud, G.C., Bruck, W.M. and Gibson, G.R., 2005. Modulation of the human gut microflora towards improved health using prebiotics-assessment of efficacy. Current Pharmaceutical Design 11: 75-90.
80. Tzortzis, G., Goulas, A.K., Gee, J.M. and Gibson, G.R., 2005. A novel galactooligosaccharide mixture increases the bifidobacterial population numbers in a continuous in vitro fermentation system and in the proximal colonic contents of pigs in vivo. Journal of Nutrition 135: 1726-1731.
81. Tzortzis, G. and Vulevic, J. (eds.), 2009. Galacto-oligosaccharide prebiotics and probiotics: science and technology. Springer, Guildford, UK.
82. Vinolo, M.A., Ferguson, G.J., Kulkarni, S., Damoulakis, G., Anderson, K., Bohlooly, Y.M., Stephens, L., Hawkins, P.T. and Curi, R., 2011. SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PloS One 6: e21205.
83. Vogt, J.A. and Wolever, T.M., 2003. Fecal acetate is inversely related to acetate absorption from the human rectum and distal colon. Journal of Nutrition 133: 3145-3148.
84. Vulevic, J., Juric, A., Tzortzis, G. and Gibson, G.R., 2013. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. Journal of Nutrition 143: 324-331.
85. Waldecker, M., Kautenburger, T., Daumann, H., Busch, C. and Schrenk, D., 2008. Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. Journal of Nutritional Biochemistry 19: 587-593.
86. Walton, G.E., van den Heuvel, E.G., Kosters, M.H., Rastall, R.A., Tuohy, K.M. and Gibson, G.R., 2012. A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. British Journal of Nutrition 107: 1466-1475.
87. Watson, D., O'Connell Motherway, M., Schoterman, M.H., Van Neerven, R.J., Nauta, A. and Van Sinderen, D., 2013. Selective carbohydrate utilization by lactobacilli and bifidobacteria. Journal of Applied Microbiology 114: 1132-1146.
88. Wen, L., Ley, R.E., Volchkov, P.Y., Stranges, P.B., Avanesyan, L., Stonebraker, A.C., Hu, C., Wong, F.S., Szot, G.L., Bluestone, J.A., Gordon, J.I. and Chervonsky, A.V., 2008. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455: 1109-1113.
89. Whary, M.T., Danon, S.J., Feng, Y., Ge, Z., Sundina, N., Ng, V., Taylor, N.S., Rogers, A.B. and Fox, J.G., 2006. Rapid onset of ulcerative typhlocolitis in B6.129P2-IL10tm1Cgn (IL-10-/-) mice infected with Helicobacter trogontum is associated with decreased colonization by altered Schaedler's flora. Infection and Immunity 74: 6615-6623.
90. Yurkovetskiy, L., Burrows, M., Khan, A.A., Graham, L., Volchkov, P., Becker, L., Antonopoulos, D., Umesaki, Y. and Chervonsky, A.V., 2013. Gender bias in autoimmunity is influenced by microbiota. Immunity 39: 400-412.